SCHEMBL17862606

SCHEMBL17862606

CC1(C)c2cc3cc(-c4ccc(-c5ccccn5)cc4)ccc3cc2-c2c1c1ccccc1c1ccccc21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABL1 P00519 3/20 0.36
▸ DHODH Q02127 1/20 0.36
▸ PDK2 Q15119 1/20 0.36
▸ KDM4E B2RXH2 2/20 0.34
▸ LMNA P02545 2/20 0.34
▸ TP53 P04637 2/20 0.34
▸ SMN1; SMN2 Q16637 2/20 0.34
▸ TSHR P16473 2/20 0.34
▸ HSD17B10 Q99714 2/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ CYP2D6 P10635 1/20 0.34
▸ CYP19A1 P11511 1/20 0.34
▸ CYP2C9 P11712 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ PKM P14618 1/20 0.34
▸ KLF5 Q13887 1/20 0.34
▸ NPSR1 Q6W5P4 1/20 0.34
▸ GSK3B P49841 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17862618 0.96 SMN1; SMN2 (0.38) ABL1DHODHPDK2KDM4ELMNA
SCHEMBL17862629 0.91 SMN1; SMN2 (0.35) ABL1PDK2KDM4ELMNATP53
SCHEMBL17862617 0.91 CCR1 (0.40) ABL1DHODHPDK2KDM4ELMNA
SCHEMBL17862628 0.90 KDM4E (0.35) ABL1PDK2KDM4ELMNATP53
SCHEMBL17862630 0.90 SMN1; SMN2 (0.38) ABL1PDK2KDM4ELMNATP53
SCHEMBL17862633 0.88 SMN1; SMN2 (0.38) ABL1PDK2KDM4ELMNATP53
SCHEMBL17862605 0.87 RARA (0.34) SMN1; SMN2DYRK1ARARARARBRARG
SCHEMBL17862619 0.86 CCR1 (0.32) KDM4ELMNATP53SMN1; SMN2TSHR
SCHEMBL17862602 0.86 PDK2 (0.36) PDK2CYP19A1GSK3BDYRK1AIRAK4
SCHEMBL17862607 0.85 RARA (0.35) TP53SMN1; SMN2PKMRARARARB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10396288-B2 Organic electroluminescent element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2019-08-27 — — US disclosed
US-20160181543-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2016-06-23 — — US disclosed
US-20160181543-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2016-06-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10396288-B2 Organic electroluminescent element and electronic device RER1, LEF1, ELP1 ABL1 2195/4885DHODH 4622/4885PDK2 4169/4885
US-20160181543-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE RER1, LEF1, RPL18 ABL1 2225/4885DHODH 4618/4885PDK2 4179/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback